Exercise CMR Assessment Could Help Identify SSc-PAH
Exercise cardiovascular magnetic resonance assessments of RV size and function may help identify patients with SSc-PAH who have poorer prognoses.
Read More
Author: Teresa Sellinger
First Line Moderate-Efficacy DMTs for MS Show Similar Efficacy
A study compared the effectiveness of first line, moderately effective disease-modifying therapies in patients with MS and found similar effectiveness.
Read More
DMT Trials for MS Show Higher Burden of Comorbidity Linked to Worse Clinical Outcomes
In clinical trials for disease-modifying therapies for patients with MS, worse clinical outcomes were associated with a higher burden of comorbidity.
Read More
Women Continue to Face Significant Healthcare System Challenges
Recent reports based on experiences and perceptions of patients and practitioners reveal that women continue to face significant healthcare system challenges.
Read More
Tips for Being an Effective Leader of the Healthcare Team
Linda Girgis, MD, FAAFP, provides expert advice on how to be an effective leader of a healthcare team, and reminds physicians that leading well takes practice.
Read More
High Depression Genetic Burden Associated With MS Disease Activity
Increased MS disease activity is associated with a higher depression genetic burden in a Canadian study.
Read More
Blood Markers Predict MS Progression
Future risk for progression independent of relapse activity can be predicted by a change in the serum glial fibrillary acidic protein, during the first 2 years of treatment for patients with MS.
Read More
Revised McDonald Criteria Allows Earlier & More Precise MS Diagnosis
The McDonald criteria for the diagnosis of MS has been updated to allow diagnosis in asymptomatic people who have had a radiologically isolated syndrome.
Read More
PW Trivia: 2025 ICD-10-CM Code Changes
PW trivia is focused on medical facts, history, and more. This week’s question is: Which ICD-10-CM chapter has the most 2025 ICD-10-CM code changes?
Read More
ICD-10 Update Season
Medical cartoon about ICD-10 codes raining down on the medical community during ICD-10-CM update season.
Read More
2025 ICD-10-CM Codes Are Now in Effect: Key Updates You Need to Know
2025 ICD-10-CM updates include new codes, code deletions and revisions, and a conversion table that identifies inactive codes and their replacements.
Read More
Q&A: Routine Screening for Neurocognitive Impairment May Improve ART Adherence
Both symptomatic and asymptomatic neurocognitive impairment in patients with HIV are associated with a higher risk for low/very low viremia and viral failure.
Read More
Neoadjuvant Nivolumab/Ipilimumab Outperforms Adjuvant Anti-PD-1 Therapy in Stage III Resectable Melanoma
Recent research showed neoadjuvant therapy with 2 cycles of nivolumab/ipilimumab outperformed 12 courses of adjuvant nivolumab in stage III resectable melanoma.
Read More
Q&A: In MS, Stigma and Access to Information Impact Disparities in Shared Decision Making
Many patients with MS from underserved populations prefer shared decision making (SDM), and SDM is important to ensure equitable access to healthcare.
Read More
Retifanlimab Improves Survival in Squamous Cell Carcinoma of the Anal Canal
Adding retifanlimab to standard-of-care chemotherapy improved response rate and progression-free survival in squamous cell carcinoma of the anal canal.
Read More
Addition of Chemoradiation to Neoadjuvant mFOLFIRINOX Shows No Benefit in BRPC
Results from the phase 2 PANDAS/PRODIGE 44 trial did not show any benefit from the addition of chemoradiation to neoadjuvant mFOLFIRINOX in patients with BRPC.
Read More
DESTINY-Breast12: T-DXd Exhibits Clinical Activity in HER2+ Breast Cancer Irrespective of Brain Metastases
T-DXd exhibited substantial and durable clinical activity in a large cohort of patients with metastatic HER2+ breast cancer, irrespective of brain metastases,
Read More
Q&A: AI in Dermatology: Current Strategies & Unmet Needs for Skin of Color
AI use is expanding in dermatology, but experts caution that more research is needed to optimize AI’s functionality for patients with skin of color.
Read More
NVL-655: Promising New Option in Pretreated, Drug-Resistant ALK-Mutated NSCLC
In the phase 1/2 ALKOVE-1 trial, the ALK-selective tyrosine kinase inhibitor (TKI) NVL-655...
Read More
Looking Ahead: The Digital Future of Allergen Immunotherapy
The fields of allergy and immunology may soon see notable increases in mobile health allergy apps and AI use for monitoring treatment adherence and symptoms.
Read More